Characterization and Stability of Tanshinone IIA Solid Dispersions with Hydroxyapatite

Area of Science:

• Pharmacology and Pharmaceutical Sciences
• Materials Science
• Drug Delivery Systems

Background:

• Tanshinone IIA (TanIIA) is a natural compound with therapeutic potential but suffers from poor solubility and bioavailability.
• Developing effective drug delivery systems is crucial to enhance the therapeutic efficacy of poorly soluble drugs like TanIIA.

Purpose of the Study:

• To prepare and characterize solid dispersions of tanshinone IIA (TanIIA) using hydroxyapatite (HAp) as a carrier.
• To evaluate the impact of HAp on the dissolution rate and stability of TanIIA.
• To assess the potential of HAp as a carrier for improving the oral absorption of TanIIA.

Main Methods:

• Solid dispersions of TanIIA with HAp (TanIIA-HAp SDs) were prepared using the solvent evaporation method.
• Characterization involved scanning electron microscopy (SEM), differential scanning calorimetry (DSC), X-ray powder diffraction (XRPD), and Fourier transform infrared (FTIR) spectroscopy.
• In vitro dissolution studies and stability assessments under room temperature for one year were conducted.

Main Results:

• Characterization confirmed the transformation of TanIIA from crystalline to amorphous form within the HAp matrix.
• FTIR analysis indicated interactions between TanIIA and HAp.
• In vitro dissolution studies showed a 7.11-fold increase in the dissolution rate of TanIIA-HAp SDs compared to free TanIIA.
• Stability studies revealed no significant changes in drug content or dissolution behavior over one year.

Conclusions:

• Hydroxyapatite (HAp) is an effective carrier for creating solid dispersions of tanshinone IIA (TanIIA).
• TanIIA-HAp solid dispersions exhibit significantly enhanced dissolution rates and good stability.
• HAp holds promise as a carrier for improving the oral absorption and therapeutic potential of TanIIA.